Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and efficacy of SI-614 ophthalmic solution for dry eye completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndromes

Drugs mentioned

• SI-614 Ophthalmic Solution (SI-614)

Snippet

Sponsor: Seikagaku Corporation | Conditions: Dry Eye Syndromes | Phase 2 | Status: COMPLETED